- Home
- APLS vs CPRI Comparison
APLS vs CPRI Comparison
Compare APLS & CPRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APLS
- CPRI
- Stock Information
- Founded
- APLS 2009
- CPRI 1981
- Country
- APLS United States
- CPRI United Kingdom
- Employees
- APLS N/A
- CPRI N/A
- Industry
- APLS Biotechnology: Pharmaceutical Preparations
- CPRI Apparel
- Sector
- APLS Health Care
- CPRI Consumer Discretionary
- Exchange
- APLS Nasdaq
- CPRI Nasdaq
- Market Cap
- APLS 2.2B
- CPRI 2.0B
- IPO Year
- APLS 2017
- CPRI 2011
- Fundamental
- Price
- APLS $17.69
- CPRI $16.82
- Analyst Decision
- APLS Buy
- CPRI Buy
- Analyst Count
- APLS 19
- CPRI 11
- Target Price
- APLS $37.67
- CPRI $21.91
- AVG Volume (30 Days)
- APLS 2.1M
- CPRI 3.1M
- Earning Date
- APLS 07-31-2025
- CPRI 08-07-2025
- Dividend Yield
- APLS N/A
- CPRI N/A
- EPS Growth
- APLS N/A
- CPRI N/A
- EPS
- APLS N/A
- CPRI N/A
- Revenue
- APLS $775,839,000.00
- CPRI $4,442,000,000.00
- Revenue This Year
- APLS $1.01
- CPRI N/A
- Revenue Next Year
- APLS $22.14
- CPRI $4.55
- P/E Ratio
- APLS N/A
- CPRI N/A
- Revenue Growth
- APLS 48.04
- CPRI N/A
- 52 Week Low
- APLS $16.10
- CPRI $11.86
- 52 Week High
- APLS $42.47
- CPRI $43.34
- Technical
- Relative Strength Index (RSI)
- APLS 42.98
- CPRI 46.41
- Support Level
- APLS $18.26
- CPRI $16.75
- Resistance Level
- APLS $19.96
- CPRI $17.50
- Average True Range (ATR)
- APLS 0.84
- CPRI 0.67
- MACD
- APLS -0.08
- CPRI -0.12
- Stochastic Oscillator
- APLS 19.22
- CPRI 14.44
About APLS Apellis Pharmaceuticals Inc.
Apellis Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel therapeutic compounds to treat diseases with high unmet needs through the inhibition of the complement system, which is an integral component of the immune system, at the level of C3, the central protein in the complement cascade.
About CPRI Capri Holdings Limited
Michael Kors, Versace, and Jimmy Choo are the brands of Capri Holdings, a marketer, distributor, and retailer of upscale accessories and apparel. Michael Kors, Capri's largest brand, offers handbags, footwear, and apparel through more than 700 company-owned stores, wholesale, and e-commerce. Versace (acquired in 2018) is known for its ready-to-wear luxury fashion, while Jimmy Choo (acquired in 2017) is best known for women's luxury footwear. In April 2025, Capri agreed to sell Versace to Prada. John Idol has served as Capri's CEO since 2003.